Incellipan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Incellipan, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: EMA Authorised: Incellipan (Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen) — Seqirus Netherlands B.V.